Chapter 13 - Diseases of the musculoskeletal system and connective tissue (M00-M99) » Inflammatory polyarthropathies (M05-M14) » Rheumatoid arthritis, unspecified (M06.9)
Related MeSH Terms
1 indication for 583 drugs (234 approved, 349 experimental)
Diseases [C] » Musculoskeletal Diseases [C05] » Joint Diseases » Arthritis » Arthritis, Rheumatoid
Diseases [C] » Musculoskeletal Diseases [C05] » Rheumatic Diseases » Arthritis, Rheumatoid
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Connective Tissue Diseases » Rheumatic Diseases » Arthritis, Rheumatoid
Diseases [C] » Immune System Diseases [C20] » Autoimmune Diseases » Arthritis, Rheumatoid
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. MeSH
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
